Connect with us


A federal court denied two of Michael Parnell’s motions.



In 2014, Federal Judge W. Louis Sands, with senior status, presided over the criminal trial of U.S. executives of the Peanut Corporation. And in the new rulings, Sands once again said “no” and “no” to the defendant Michael Parnell, who sought both a “compassionate release” and an overturning of his conviction on constitutional grounds.

It spells defeat for Parnell, 64, who was a peanut broker for the PCA, when his peanut processing plant in Blakely, Georgia, was discovered to be the source of a deadly salmonella outbreak in several states. He is currently in Fort Dix, New Jersey federal prison, serving a 20-year sentence.

In the motion, originally filed in February 2021, Parnell asked “the court to reduce and suspend his remaining term of incarceration so that he can be placed under electronic home surveillance at his Virginia residence for as long as the court deems reasonable and then placed in custody.” . supervised probation.”

On February 15, 2013, Parnell was charged with alleged conspiracy to commit mail fraud and wire fraud, conspiracy to introduce adulterated food into interstate commerce, conspiracy to introduce adulterated food into interstate commerce, introducing adulterated and misbranded foodstuffs into interstate commerce with intent to deceive or mislead, interstate delivery fraud, electronic fraud, and obstruction of justice.

In September 2014, after a seven-week jury trial, Parnell was found guilty of conspiracy to commit mail fraud and wire fraud, conspiracy to introduce adulterated and substandard food into interstate commerce with intent to deceive or mislead misleading, and multiple counts of mislabeling food products in interstate commerce, multiple mail fraud, and multiple electronic communications fraud.

He was acquitted of all charges of introducing adulterated food into the interstate commerce. He was sentenced to 240 months in prison, followed by a supervised release for three years. The verdict was upheld on appeal by the 11th Federal District Court of Atlanta.

While applying for a compassionate release in 2021, Parnell said there were “extraordinary and compelling reasons” including the fact that he is 61 years old, overweight and suffers from chronic debilitating conditions including type 2 diabetes. and hypertension.

He also argued that “FCI Fort Dix, the federal correctional facility where the defendant is currently located, contracted COVID-19 and the security plan provided by the Bureau of Prisons is ‘virtually impossible’ to comply with due to narrow corridors that make social distancing impossible.” and poor indoor air circulation.

Sands obtained Parnell’s medical records through the U.S. Probation Service and, upon review, found “no extraordinary or compelling reason that would warrant a compassionate release.” He said Parnell “points to medical causes such as clinical overweight, type II diabetes and hypertension. But, according to the main policy statement, the only medical conditions that rise to the level of extraordinary and compelling reasons are those that (i) are terminal illnesses or (ii) “substantially impair the defendant’s ability to provide self-care” within prison.

Sands said he “agrees with the government that simply pointing out the existence of his medical condition is not sufficient” as Parnell “has not demonstrated that his condition is not being properly treated or managed, or that his ability to care for himself in prison is significant.” limited.” reduced as a result of his medical conditions.”

The US Probation Department stated that Parnell was “prescribed various medications for hypertension, diabetes, and liver disease.” He also received Covid 19 vaccines.

“After a thorough and complete examination of the record, the motion and response, the applicable factors pursuant to § 3553(a), and the relevant policy statements of the Sentencing Commission, the defendant’s motion for compassionate release REJECTEDSands decided.

Following the hearing, U.S. Justice of the Peace Thomas K. Langstaff had previously found that Parnell had failed to establish evidence that his trial attorney provided ineffective assistance and therefore recommended against 2255 Moton that the conviction and conviction be overturned.

Langstaff’s report was submitted to Sands for either acceptance or rejection, and he fully supports the magistrate’s findings and the denial of Parnell’s motion.

Parnell and his brother Stuart Parnell, former president of the Peanut Corporation of America (PCA). were among those who pointed out the salmonellosis outbreak in 2008-09.

Michael Parnell managed PCA’s sales of peanut butter to Kellogg. Prior to its closure in 2009, PCA manufactured and sold peanut products to food manufacturers in the United States.

Federal authorities have identified a PCA manufacturing plant in Blakely, Georgia as the source of a nationwide salmonellosis outbreak. After a four-year investigation, the Parnell brothers were charged with their food safety behavior at the PCA.

This is how Sands recalls what happened:

“In court, the government presented evidence that plaintiff Michael Parnell, his brother, and co-defendant Stewart colluded with PCA senior management to defraud its customers about the safety of its products.

“At the direction of Stuart Parnell, the PCA retested a product that tested positive for Salmonella until it tested negative, or shipped a product before it received test results for that product, and even shipped a product after it tested positive. The government also presented evidence of a scheme designed by Stewart, Michael and other top management to help the PCA meet manufacturing needs on Kellogg’s behalf. In September 2007

“PCA has begun assigning future batch numbers to peanut butter samples submitted for testing. They used those test results to create certificates of analysis for new batches of peanut butter she sent to Kellogg’s. The Certificate of Analysis for Kellogg orders contained test results from a sample taken from a previous batch. The shipped batch has not been tested. The PCA took samples from the new batch, assigned future batch numbers to those samples, and sent them out for testing to keep the practice going. The PCA did not tell Kellogg’s if a batch that had already been shipped tested positive.

Between January 2008 and January 2009, more than 60 percent of Kellogg’s pasta shipments were not subjected to any microbiological testing. Plaintiff Michael Parnell, along with other defendants, knew that the PCA had tested positive for salmonellosis prior to the Salmonella outbreak. But they were not provided by the FDA during the investigation.”

Michael Parnell filed Motion 2255 for release on March 5, 2019. It is sometimes referred to as the Habeus Corpus petition. Stuart Parnell’s Petition 2255, also filed in 2019, was also denied by Sands and is currently on appeal in the 11th Circuit in federal court.

Michael Parnell argued, “His attorney, Mr. Ed Tolley, provided ineffective assistance by (1) not proposing a change of venue, (2) not striking the jury in the case, who were aware of the allegations of death from a salmonella outbreak.” , (3) failure to investigate witnesses who were brought to the attention of counsel that could materially discredit key government witnesses, and (4) failure to investigate after it emerged that the jury was potentially influenced by out-of-court information.”

Sands considered these “objections groundless”.

Thousands fell ill with salmonella due to PCA peanut butter and peanut butter contamination in 2008–2009, and the outbreak killed nine people.

(To sign up for a free subscription to Food Safety Newsletter, click Here)


Ben & Jerry’s Co-Founder Starts Nonprofit Cannabis Company



One of the co-founders of Ben & Jerry’s moved from ice cream to cannabis with a social mission.

WILLISTON, Virginia. — One of Ben’s co-founders & Jerry’s has moved from ice cream to cannabis with a social mission.

Ben Cohen launched Ben’s Best Blnz, a non-profit cannabis line with a stated mission to help right the wrongs of the drug war. The company says on its website that 80% of its profits will go to grants for black cannabis entrepreneurs, with the remainder split equally between the Vermont Racial Justice Alliance and the Last Prisoner National Project, which works to free people imprisoned in prison for cannabis-related crimes. .

“The War on Drugs (first named as such by President Richard Nixon) is targeting low-income blacks and browns through police harassment, discriminatory prosecutions, and discriminatory sentencing,” the website says. “That’s why, despite using marijuana at the same rate, blacks are 4 times more likely to get arrested than whites.”

Ben’s Best Blnz, or B3, says it licenses its formulas, packaging, trademarks and marketing materials to commercial enterprises that pay royalties. After expenses are deducted, royalties are donated to the cause.

Cannabis is grown in soil without the use of inorganic fertilizers, pesticides, herbicides or fungicides, the website says.

B3 products, including pre-rolled joints with lower levels of the psychoactive compound THC, are expected to be available in cannabis stores in Vermont next month.

Continue Reading


When Cancer and Pregnancy Intersect, It’s Depressing in Every Way – We Need Better Support | Naama Karlin



I discovered a lump in my breasts in my second trimester. This was my first pregnancy, and since there was no breast cancer in my family, I was not alarmed by this change. When I complained to my antenatal team via Telehealth (I got pregnant during the Delta Covid wave in Sydney) they said it could be a blocked milk duct. No one suggested I come in for a physical or suggested that the changes in my breasts were related to anything other than pregnancy.

My suspicions arose only after my general practitioner examined me as part of a standard doctor’s visit. He sent me for an emergency ultrasound. A week later, I was admitted for a biopsy at the oncology center. After receiving the biopsy result a few days before Christmas, the reality hit me: I was pregnant with cancer.

Although cancer diagnoses during pregnancy are considered rare, study showed that melanoma and breast cancer are among the two most common cancers diagnosed during pregnancy in Australia. Because of its prevalence, most research is focused on gestational breast cancer (GBC), which I was diagnosed with at 29 weeks.

Pregnant women diagnosed with GBC often delay seeking medical attention because they believe their symptoms are due to natural changes in their body, such as breast pain and tissue changes due to pregnancy hormones. This delay, and the common assumption that any breast change during pregnancy is hormonal and normal, is one reason why GBC may be more pronounced at onset (larger tumor size and lymph node involvement) than non-GBC. according to the Royal Australian College of General Practitioners (RAKGP). Despite the rise in cancer rates during pregnancy, a recent study found that, unfortunately, people with a diagnosis often do not receive the support they need.

I say anxiously because cancer and pregnancy are two major life events, and when they intersect, their combined impact is overwhelming in every way: physical, psychological, financial. Few things make you plan ahead like pregnancy, and nothing makes that future more uncertain than cancer. A recent article stated that, despite its increasing prevalence, the psychosocial problems associated with cancer diagnosis during pregnancy “remain an under-researched topic”. Existing research indicates that those who are pregnant with cancer experience significant stress and require significant supportive care, which is often not met even after the pregnancy is over.

A common theme emerged in my network of women diagnosed with GBC: We felt isolated and even stigmatized by being cancer patients. We felt guilty about being treated during pregnancy, even though we were made clear that chemotherapy was safe. We were worried about an uncertain future. Our experience was exacerbated by rising financial costs. In addition to newborn costs, we now had to account for cancer-related costs, such as specialist fees, break fees, medications, and treatment for side effects.

One area that needs attention is coordination between oncology and antenatal teams. In New South Wales, where I live, babies born to women with GBC (or any other cancer) most likely premature and require additional medical care, such as stays in neonatal care units. In my case, labor had to be induced as our baby’s growth slowed down. While both the antenatal and oncology teams provided exceptional care, coordination between these commands felt unclear at times. It became apparent that some of the antenatal side didn’t know how to “handle” the cancerous part of my pregnancy and delivery. In such an elementary thing as the transfer of medical records in the maternity ward, I was misdiagnosed with cancer. The system was not designed to support patients between two supposedly disparate parts of it. My experience is not unique.

I have been fortunate to receive first class care from my medical team (led by my oncologist who goes the extra mile). But caution should be built into the system already, not by chance. We must ensure that conversations about breastfeeding and fertility after treatment are treated with sensitivity. Invest in training neonatal and postpartum healthcare workers about cytotoxicity. Ensure effective coordination of health systems when it comes to supporting patients with overlapping diagnoses and needs. Make counseling available to pregnant cancer patients and their families. And finally, increase financial support for care. As a young mom undergoing cancer treatment, I relied on charities (such as the Australian Mom’s Wish Foundation and the Hope for Two Network) for ad hoc financial support. I also had to fundraise for immunotherapy treatments that cost over $60,000. It shouldn’t be. Health care and related support must be accessible to all.

Being diagnosed with cancer during pregnancy can be overwhelming, isolating, and daunting. While the study says such diagnoses are rare, it seems like every week a new woman reaches out to us to share her diagnosis and fears. For those who are going through this: you are not alone. Our healthcare system: We need better support and communication with pregnant cancer patients. Now that the stakes are rising, it’s time for meaningful change.

Naama Karlin is a scientist and writer living in the unseen land of Bijigal. Her co-authored book Being Patient: Close Encounters in the World of Cancer (NewSouth Press) is forthcoming.

Continue Reading


Benefits of partnering with a lead generation agency and how to choose the right one




Lead generation is an important aspect of marketing that involves identifying and developing potential customers. A lead generation agency is a specialized firm that helps companies generate new leads and target them through various marketing channels.

These agencies use several techniques such as search engine optimization, email campaigns, social media outreach, content marketing, and other digital strategies to generate qualified leads that can turn into paying customers. Thanks to their knowledge and experience, lead generation agency can create effective campaigns that drive more quality leads into the business’s sales funnel, resulting in increased revenue and customer loyalty.

Benefits of working with a lead generation agency

Partnering with a lead generation agency offers many benefits for companies of all sizes. These benefits include greater dissemination and visibility, access to expertise and resources, and cost savings and efficiency gains.

Increased exposure and visibility

One of the main benefits of partnering with a lead generation company is increased exposure. Lead generation agencies have extensive networks spanning multiple industries and access to databases containing valuable lead information. This data allows them to create targeted campaigns that reach their target audience in the most efficient way. Plus, they have dedicated tools to help them track response rates so they can adjust their campaigns accordingly for maximum success. This type of insight is invaluable when it comes to building awareness for your business or brand.

Access to experience and resources

Lead generation agencies also provide access to expert professionals who have extensive knowledge of generating leads through various channels such as email campaigns, social media, search engine optimization (SEO), etc. These experienced professionals know how to position a product or service to attract potential customers interested in what the business has to offer. In addition, these agencies typically provide additional resources such as marketing automation software, lead scoring tools, and analytics dashboards that help companies improve their lead generation efforts.

Savings and efficiency

Partnering with a lead generation agency can also help companies cut costs and improve process efficiency. By outsourcing lead generation efforts to an experienced agency, businesses can avoid the costs associated with hiring and training new employees, acquiring marketing tools and software, and managing campaigns in-house. Lead generation agencies also have the experience and resources to manage campaigns more effectively, resulting in a higher return on investment (ROI) for the business.

Features of a good lead generation agency

When choosing a lead generation agency, you should pay attention to several key characteristics. These include a comprehensive service package, experienced team members and a proven track record of successful campaigns.

Comprehensive service package

A good lead generation agency will have a comprehensive package of services that covers all aspects of lead generation from strategy development and campaign planning to implementation and results analysis. This type of package ensures that all aspects of a campaign are managed with meticulous attention to every detail so that businesses get the highest possible return on investment (ROI).

Experienced team members

Experienced team members are critical to successful lead generation campaigns. When choosing a lead generation agency, companies should choose a team with proven experience and technical expertise. These team members must also have the creative vision to develop effective campaigns that are specifically tailored to the needs of the business. They need to understand how technology works together with marketing methods so they can deliver maximum campaign reach to target customers.

Proven track record of successful campaigns

An experienced team member is only as good as their performance, so it’s also important to consider their track record in terms of successful past campaigns when choosing an agency. This includes analyzing case studies, testimonials and reviews from other clients in similar industries or markets.

How to choose the right lead generation agency for your business

Choosing the right lead generation agency for your business can be a daunting task. However, reviewing goals and objectives, researching potential agencies, and evaluating cost versus value proposition can help you along the way. It’s also worth noting that when evaluating cost versus value proposition, it’s important to keep in mind that a cheaper agency may not necessarily provide the same level of expertise or deliver the same quality of results as a more expensive agency. Therefore, it is important to consider the long-term benefits of working with a more experienced and successful agency that can provide a higher return on investment.

property values. Manager with a calculator. Real estate investment.

In conclusion, partnering with a lead generation agency is a great way to grow your business’s customer base and increase sales. With their specialized services, businesses can target specific consumer groups, develop strategies for successful lead conversion, and track results. By choosing the right lead generation agency, companies can quickly expand their footprint and accelerate their growth. However, it’s important to keep your goals and objectives in mind, research potential agencies, and evaluate their value against the value proposition before making a decision.

Continue Reading